Yishuo Wu

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

Rong Na, Shusen Zheng, Misop Han et al. · European Urology · 2016 · 341 citations · Full text

Medicine, Genetics, Oncology +17

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

H. Ballentine Carter, Brian T. Helfand, Mufaddal Mamawala et al. · European Urology · 2018 · 211 citations

Medicine, Genetics, Oncology +17

A comprehensive evaluation of <i>CHEK2</i> germline mutations in men with prostate cancer

Yishuo Wu, Hongjie Yu, Shusen Zheng et al. · The Prostate · 2018 · 75 citations

Medicine, Genetics, Molecular Genetics +17

HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria

Yishuo Wu, Guangliang Jiang, Ning Zhang et al. · European Urology Focus · 2018 · 66 citations

Medicine, Oncology, Urology +16

Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer

Yishuo Wu, Hongjie Yu, Shuwei Li et al. · European Urology Oncology · 2020 · 56 citations

Medicine, Oncology, Urology +16